These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 19217514)

  • 1. Other therapies for reducing low-density lipoprotein cholesterol: medications in development.
    Stein EA
    Endocrinol Metab Clin North Am; 2009 Mar; 38(1):99-119. PubMed ID: 19217514
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The ebbs and flows in the development of cholesterol-lowering drugs: prospects for the future.
    Hajhosseiny R; Sabir I; Khavandi K; Wierzbicki AS
    Clin Pharmacol Ther; 2014 Jul; 96(1):64-73. PubMed ID: 24699033
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel therapeutic agents for lowering low density lipoprotein cholesterol.
    Joy TR
    Pharmacol Ther; 2012 Jul; 135(1):31-43. PubMed ID: 22465160
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human cholesterol metabolism and therapeutic molecules.
    Charlton-Menys V; Durrington PN
    Exp Physiol; 2008 Jan; 93(1):27-42. PubMed ID: 18165431
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel therapies and new targets of treatment for familial hypercholesterolemia.
    Goldberg AC
    J Clin Lipidol; 2010; 4(5):350-6. PubMed ID: 21122677
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel nonstatin strategies to lower low-density lipoprotein cholesterol.
    Davidson MH
    Curr Atheroscler Rep; 2009 Jan; 11(1):67-70. PubMed ID: 19080731
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New therapies for reducing low-density lipoprotein cholesterol.
    Stein EA; Raal FJ
    Endocrinol Metab Clin North Am; 2014 Dec; 43(4):1007-33. PubMed ID: 25432394
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular pathways and agents for lowering LDL-cholesterol in addition to statins.
    Costet P
    Pharmacol Ther; 2010 Jun; 126(3):263-78. PubMed ID: 20227438
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New targets and emerging therapies for reducing LDL cholesterol.
    Lilly SM; Rader DJ
    Curr Opin Lipidol; 2007 Dec; 18(6):650-5. PubMed ID: 17993811
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel strategies for managing dyslipidemia: treatment beyond statins.
    Ling H; Burns TL; Hilleman DE
    Postgrad Med; 2012 Nov; 124(6):43-54. PubMed ID: 23322138
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low-density lipoprotein lowering in 2013 by nonstatin agents: the discovery and development of promising novel targeted therapies.
    Kohli P; Giugliano RP
    J Cardiovasc Pharmacol Ther; 2013 May; 18(3):199-210. PubMed ID: 23580658
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Advancing therapy for hypercholesterolemia.
    Toutouzas K; Drakopoulou M; Skoumas I; Stefanadis C
    Expert Opin Pharmacother; 2010 Jul; 11(10):1659-72. PubMed ID: 20509773
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New lipid-lowering drugs: an update.
    Wierzbicki AS; Hardman TC; Viljoen A
    Int J Clin Pract; 2012 Mar; 66(3):270-80. PubMed ID: 22340447
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lipid parameters and cardiovascular events in patients taking statins.
    Brook RD; Rubenfire M
    JAMA; 2012 Jul; 308(2):132; author reply 132-3. PubMed ID: 22782403
    [No Abstract]   [Full Text] [Related]  

  • 15. Lipid parameters and cardiovascular events in patients taking statins.
    Martin SS; Jones SR
    JAMA; 2012 Jul; 308(2):131-2; author reply 132-3. PubMed ID: 22782402
    [No Abstract]   [Full Text] [Related]  

  • 16. New lipid-lowering agents acting on LDL receptors.
    Scharnagl H; März W
    Curr Top Med Chem; 2005; 5(3):233-42. PubMed ID: 15857307
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting low HDL-cholesterol to decrease residual cardiovascular risk in the managed care setting.
    Cziraky MJ; Watson KE; Talbert RL
    J Manag Care Pharm; 2008 Oct; 14(8 Suppl):S3-28; quiz S30-1. PubMed ID: 19891279
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mipomersen: a safe and effective antisense therapy adjunct to statins in patients with hypercholesterolemia.
    Ricotta DN; Frishman W
    Cardiol Rev; 2012; 20(2):90-5. PubMed ID: 22293857
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Statins remain the standard. New methods for lipid lowering therapy].
    Aumiller J
    MMW Fortschr Med; 2001 Oct; 143(42):16-7. PubMed ID: 11697281
    [No Abstract]   [Full Text] [Related]  

  • 20. Impact of nonprescriptive factors on low-density lipoprotein cholesterol reduction with statins.
    Frolkis JP; Pearce GL; Sprecher DL
    Am J Cardiol; 2004 Nov; 94(10):1310-2. PubMed ID: 15541255
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.